Molbio Diagnostics reports Q1 FY26 financial results

Molbio Diagnostics reports Q1 FY26 financial results. The company released its unaudited financial results for the quarter ended June 30, 2026. Key metrics include revenue of ₹82.4 crore and net profit of ₹14.2 crore, showing growth of 18% and 22% year-on-year, respectively. Operational margins improved due to higher export demand and cost optimization.
📊 STOCKS: $MOLBIO | 🏢 SECTOR: Healthcare | #MEDIUMIMPACT #Earnings